6-25845396-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001098486.2(SLC17A3):c.1483C>T(p.Leu495Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098486.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC17A3 | NM_001098486.2 | c.1483C>T | p.Leu495Phe | missense_variant | 12/13 | ENST00000397060.8 | |
LOC124901285 | XR_007059518.1 | n.379+8864G>A | intron_variant, non_coding_transcript_variant | ||||
SLC17A3 | NM_006632.4 | c.1249C>T | p.Leu417Phe | missense_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC17A3 | ENST00000397060.8 | c.1483C>T | p.Leu495Phe | missense_variant | 12/13 | 2 | NM_001098486.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251292Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135812
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461704Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727148
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.1249C>T (p.L417F) alteration is located in exon 11 (coding exon 10) of the SLC17A3 gene. This alteration results from a C to T substitution at nucleotide position 1249, causing the leucine (L) at amino acid position 417 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at